Tenapanor in Synucleinopathy-Related Constipation

NCT06460038 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Synucleinopathy
Parkinson's Disease

Interventions

DRUG: Tenapanor
DRUG: Placebo

Sponsor

Cedar Valley Digestive Health Center

Collaborators

[object Object]